Literature DB >> 11556826

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer.

D Coradini1, P Boracchi, M G Daidone, C Pellizzaro, P Miodini, M Ammatuna, G Tomasic, E Biganzoli.   

Abstract

The prognostic contribution of intratumour VEGF, the most important factor in tumour-induced angiogenesis, to NPI was evaluated by using flexible modelling in a series of 226 N-primary breast cancer patients in which steroid receptors and cell proliferation were also accounted for. VEGF provided an additional prognostic contribution to NPI mainly within ER-poor tumours. Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11556826      PMCID： PMC2375079          DOI： 10.1054/bjoc.2001.2019

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  17 in total

1.  Validation of existing and development of new prognostic classification schemes in node negative breast cancer. German Breast Cancer Study Group.

Authors:  W Sauerbrei; K Hübner; C Schmoor; M Schumacher
Journal:  Breast Cancer Res Treat       Date:  1997-01       Impact factor: 4.872

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

Review 4.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

5.  Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.

Authors:  B Linderholm; K Grankvist; N Wilking; M Johansson; B Tavelin; R Henriksson
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

6.  Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

Authors:  R Heimann; D Ferguson; C Powers; W M Recant; R R Weichselbaum; S Hellman
Journal:  J Natl Cancer Inst       Date:  1996-12-04       Impact factor: 13.506

7.  Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.

Authors:  R Silvestrini; M G Daidone; A Luisi; P Boracchi; M Mezzetti; G Di Fronzo; S Andreola; B Salvadori; U Veronesi
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

8.  Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer.

Authors:  H Yoshiji; D E Gomez; M Shibuya; U P Thorgeirsson
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

9.  The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  I Balslev; C K Axelsson; K Zedeler; B B Rasmussen; B Carstensen; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640
View more
  5 in total

1.  The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study.

Authors:  Ying Liu; Rulla M Tamimi; Laura C Collins; Stuart J Schnitt; Hannah L Gilmore; James L Connolly; Graham A Colditz
Journal:  Breast Cancer Res Treat       Date:  2011-03-09       Impact factor: 4.872

Review 2.  Biomolecular features of clinical relevance in breast cancer.

Authors:  Maria Grazia Daidone; Angelo Paradiso; Massimo Gion; Nadia Harbeck; Fred Sweep; Manfred Schmitt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-17       Impact factor: 9.236

3.  Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence.

Authors:  D Coradini; C Pellizzaro; S Veneroni; L Ventura; M G Daidone
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

4.  The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

Authors:  P Manders; L V A M Beex; V C G Tjan-Heijnen; J Geurts-Moespot; T H Van Tienoven; J A Foekens; C G J Sweep
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

5.  Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen.

Authors:  D Coradini; E Biganzoli; C Pellizzaro; S Veneroni; S Oriana; F Ambrogi; R Erdas; P Boracchi; M G Daidone; E Marubini
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.